Personal information

No personal information available

Activities

Collapse all

Works (3)

Combination chemotherapy consisting of irinotecan, etoposide, and carboplatin for refractory or relapsed neuroblastoma

Cancer Medicine
2022-05 | Journal article
DOI: 10.1002/cam4.4529
Contributors: Masayuki Imaya; Hideki Muramatsu; Atsushi Narita; Ayako Yamamori; Manabu Wakamatsu; Taro Yoshida; Shunsuke Miwata; Kotaro Narita; Daisuke Ichikawa; Motoharu Hamada et al.
Source: check_circle
Crossref

Minor PNH clones do not distinguish inherited bone marrow failure syndromes from immune-mediated aplastic anemia

Blood Advances
2022-04-26 | Journal article
DOI: 10.1182/bloodadvances.2021006044
Contributors: Atsushi Narita; Shunsuke Miwata; Masayuki Imaya; Yusuke Tsumura; Ayako Yamamori; Manabu Wakamatsu; Motoharu Hamada; Rieko Taniguchi; Yusuke Okuno; Hideki Muramatsu et al.
Source: check_circle
Crossref

Combination chemotherapy consisting of irinotecan, etoposide, and carboplatin (IREC) for refractory or relapsed neuroblastoma

2020-12-28 | Preprint
DOI: 10.22541/au.160911726.62502335/v1
Contributors: Masayuki Imaya; Hideki Muramatsu; Atsushi Narita; Ayako Yamamori; Manabu Wakamatsu; Taro Yoshida; Shunsuke Miwata; Kotaro Narita; Daisuke Ichikawa; Motoharu Hamada et al.
Source: check_circle
Crossref
How many people are using ORCID?